<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE326nnn/GSE326853/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><species> Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE326853</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Transcriptome analysis of treated and control samples from bladder carcinoma</name><description>We provide bulk RNA-seq data for the following: (1) Relapsed tumors after Gemcitabine treatment and their corresponding control tumors, derived from a genetically engineered mouse model (GEMM) of bladder carcinoma. (2) IGFBP5 knockout (KO) MP-MGH-U3-LT and CUUC-G cell lines and their corresponding control cell lines.</description><dates><publication>2026/04/07</publication></dates><accession>GSE326853</accession><cross_references><GSM>GSM9641309</GSM><GSM>GSM9641308</GSM><GSM>GSM9641297</GSM><GSM>GSM9641296</GSM><GSM>GSM9641299</GSM><GSM>GSM9641298</GSM><GSM>GSM9641293</GSM><GSM>GSM9641292</GSM><GSM>GSM9641295</GSM><GSM>GSM9641294</GSM><GSM>GSM9641305</GSM><GSM>GSM9641304</GSM><GSM>GSM9641307</GSM><GSM>GSM9641306</GSM><GSM>GSM9641301</GSM><GSM>GSM9641300</GSM><GSM>GSM9641303</GSM><GSM>GSM9641302</GSM><GPL>24676</GPL><GPL>24247</GPL><GSE>326853</GSE><taxon>Mus musculus</taxon><taxon> Homo sapiens</taxon></cross_references></HashMap>